Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

IRRAS Establishes Collaborative Relationship with AMI-USC Through Acquisition of Complementary Medical Device Technology

Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California (AMI-USC) is a World Class Biomedical Engineering Technology Development OrganizationStockholm, April 23, 2019 – IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical-technology company focused on developing and commercializing innovative solutions for intracranial bleeding pathologies, announced today it has entered into an agreement with the Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California (AMI-USC). Under the terms of the agreement,

Herantis Pharma Announces 12-Month Follow-Up Review from Phase 1 Lymfactin Trial in Breast Cancer-Associated Lymphedema

Herantis Pharma Announces 12-Month Follow-Up Review from Phase 1 Lymfactin® Trial in Breast Cancer-Associated Lymphedema Herantis Pharma PlcCompany release 23 April 2019 at 9:00 am Herantis Pharma Plc (“Herantis”) announced today the topline results from the 12-month follow-up review of the Phase 1 Lymfactin® trial in breast cancer-associated lymphedema. The study’s data monitoring committee (DMC) concluded that the treatment continues to be safe and well-tolerated in all patients with no severe adverse events. Lymfactin®, the novel gene therapy of Herantis that aims to repair the

Orkla ASA: Invitation to presentation of Orkla's first quarter 2019 results, Tuesday 7 May

Orkla will report its first quarter 2019 results on Tuesday, 7 May at 7.00 a.m. CET. The quarterly report and the presentation material will be available at this time at www.orkla.com.The quarterly results will be presented at 8.00 a.m. at the Orkla House, Drammensveien 149, Oslo. The presentation and subsequent Q&A session will be held in English and may be viewed in a live webcast at www.orkla.com or followed by telephone. Dial-in details: +47 21 03 33 94. Pincode: 1661193. To attend the presentation in Oslo, please register in advance by sending an email to: sara.freiman@orkla.no.

Share buy-backs in Telia Company during week 16 2019

During the period April 16, 2019, until April 18, 2019, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 1,672,000 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on April 16, 2019. The share buy-back programme, which runs between April 16, 2019, and February 28, 2020, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period

Correction: Endomines Ore Reserve and Mineral Resource Estimate update

Endomines AB, stock exchange release 23 April 2019 at 07:30 CESTThis is a correction to Endomines stock exchange release issued on April 9, 2019 at 13:00 CEST regarding Endomines ore reserve and mineral resource update. In the table presenting Mineral Resources – Karelian Gold Line, figures for the Pampalo Inferred Total and Karelian Measured + Indicated Total for kg and grade (Au g/t) were not correct. Please find below the original stock exchange release with the correct tables. Endomines is pleased to announce its 2019 gold reserve and resource estimates for its Pampalo mine and the

BerGenBio to present NSCLC and AML clinical data from Phase II development programme with selective AXL inhibitor bemcentinib at ASCO 2019

· Phase II data in AML combining bemcentinib with low-dose chemotherapy and NSCLC combining with KEYTRUDA · Accepted for presentation at ASCO in June 2019Bergen, Norway, 23 April 2019 – BerGenBio ASA (OSE: BGBIO) a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer indications, announces that the Company and its collaborators will present new interim clinical and biomarker data from its extensive Phase II clinical development programme with bemcentinib, a selective, oral AXL inhibitor, at the 2019 annual meeting of the American

Fabege outperforms the Swedish energy agreement

Sweden’s long-term focus for Swedish energy policy, Energiöverenskommelsen (the energy policy agreement), sets a target of 50 per cent more efficient energy consumption in 2030 compared to 2005. Fabege already achieved an actual reduction in energy consumption for its entire portfolio of investment properties of 49 per cent back in 2018 and is now pressing on with its efficiency efforts.Fabege’s new energy efficiency target is divided into stages, the aim being to meet the first “50 per cent target” this year. The next milestone, which is expected as early as 2023, is an average energy

Micro-LEDs achieve superior brightness with Picosun’s ALD technology

ESPOO, Finland, 23rd April 2019 – Picosun Group, supplier of the leading AGILE ALD™ (Atomic Layer Deposition) thin film coating solutions, reports superb results in boosting micro-LED performance using ALD passivation. Micro-LEDs are a strong challenger to existing display technologies such as LCDs (liquid crystal displays), OLEDs (organic light-emitting diodes) or conventional LEDs (light-emitting diodes). Offering compact size, low power consumption, superior brightness and energy efficiency, greater contrast and color saturation, ultra-high resolution, flexibility and good reliability,

Elkem Silicones at Electric & Hybrid Vehicle Technology Expo Europe 2019

Elkem Silicones showcases advanced materials for Battery technology and Electronic components at Electric & Hybrid Vehicle Technology Expo Europe 2019.Our global technical team will present you our solutions for thermal management, fire protection and assembly at Electric & Hybrid Vehicle Technology Expo Europe in Stuttgart, May 7th to 9th, 2019. At Elkem Silicones, we are playing an active role in developing next generation materials that meet the requirements of electric and hybrid vehicle applications. Discover our solutions for thermal management (thermally conductive adhesives, gap

Africa Oil Announces Voting Results from Annual General and Special Meeting

VANCOUVER, April 18, 2019 /CNW/ – Africa Oil Corp. (AOI–TSX, AOI–Nasdaq-Stockholm) (“Africa Oil” or the “Company”) held its annual meeting of shareholders in Vancouver, British Columbia today. Shareholders voted as follows on the matters before the meeting: Election of Directors Shareholders elected the following six (6) board members to serve on the Company’s board of directors until the next annual meeting of shareholders or until their successors are elected or appointed: +---------------+-----------+------+---------+----------+|Nominee | For |% For |Withheld |%

IFS once again a Leader in the Gartner 2019 Magic Quadrant for Field Service Management

IFS has been recognized as a Leader in every Gartner Magic Quadrant for FSM published since 2014 IFS , the global enterprise applications company, believes its IFS Field Service Management™  (FSM) suite further cement its leadership credentials with its placement in the Gartner Magic Quadrant for Field Service Management*.It has been another transformational year for IFS in the FSM space, during which time the company has: · Launched the class-leading IFS FSM 6,

Peptonic Medical AB (publ) issues its Annual Report 2018

Stockholm, April 18th 2019. - Peptonic Medical (publ)  -  today announces that its 2018 Annual Report is available on the Company’s website www.peptonicmedical.se  and on the website of Spotlight www.spotlightstockmarket.com.In the Auditor’s Report the following information is presented under the heading ‘Additional Information’ (sv. Övriga upplysningar): “We refer to the Annual Report that states that a need for additional financing may occur during the coming 12 months and that there is always the possibility to turn to the shareholders, however, there is no absolute guarantee that a

CORRECTION: INTERIM REPORT JANUARY - MARCH 2019

A reference to the EU Market Abuse Regulation was not included in the press release published at 08:00 CET on 17 April 2019. The correct reference follows below.Interim Report January - March 2019 The first quarter entailed a positive start to the year: sales and profitability increased, both gross margin and cost control were strong, the market grew and Byggmax continued to take market share. Weather conditions were better than previous year, although not as favorable as in 2017. First quarter 2019: •Net sales increased by 7.5 percent to SEK 715.4 M (665.2) •Gross margin

CORRECTION: ANNUAL REPORT 2018

A reference to the Securities Markets Act was not included in the press release published at 09:00 CET on 18 April 2019. The correct reference follows below.Annual Report 2018 Byggmax Group AB (publ) Annual Report 2018 Byggmax Group AB (publ) This is information that Byggmax Group AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 09:00 CET on 18 April 2019. Annual Report 2018 

Record growth and continued transformation

2018 was an exceptional year of development for Keolis with many tenders won and growth in turnover and EBITDA of +10% and +15% respectively. · At €5.93 Bn, turnover increased significantly notably thanks to the contract signed with Transport for Wales, and is now approaching the €6 billion milestone. · This strong growth in turnover comes with an even larger increase in profitability (recurring EBITDA), which rose by 15% in 2018, from €342 M to €392 M. · Operating margin is 6.6%.   “Keolis continues its development, with two-digit growth and a significant increase in its

Heliospectra’s Incentive Program Transfer Stock Warrants to Senior Executives and Key Personnel

Heliospectra AB (publ) ("the Company") has through the wholly owned subsidary Heliospectra Personal AB ("the Subsidiary") today executed the transfer of 905,000 stock warrants of series P02 from the Company to a total of 25 senior executives and / or key personnel within the group. The stock warrants were originally issued to the Subsidiary at the Company’s Extra Ordinary General Meeting held on March 12, 2019.In accordance with the terms of the stock warrants, the Company has established the market value of the warrants per transfer day in accordance with the Black & Scholes option

Notice to attend Acando AB’s Annual General Meeting 22 May 2019

The shareholders of Acando AB (publ), Reg. No. 556272-5092, are hereby convened to the Annual General Meeting of shareholders (AGM) to be held on Wednesday, 22 May 2019 at 16.00, at Cirio Advokatbyrå, Mäster Samuelsgatan 20, Stockholm, Sweden.NOTIFICATION OF INTENTION TO ATTEND, AND RELATED ITEMS Shareholders who wish to attend the AGM must ·  be listed in the register of shareholders maintained by Euroclear Sweden AB Thursday 16 May 2019; ·  and notify Acando of their intention to attend the AGM at the latest by 12 noon on Thursday 16 May 2019. Notification of intention to

ZF and Foton Open Joint Transmission Plant in China, Advancing Automation for Commercial Vehicles

· Joint plant in Jiaxing to produce automatic commercial vehicle transmissions for the Chinese market · Partners see excellent market potential for automated commercial vehicles in the next five yearsFriedrichshafen/Jiaxing. At the end of 2016, ZF entered into two joint ventures with Foton, a Chinese commercial vehicle manufacturer, to produce and sell commercial vehicle transmissions. The partners have now opened a production plant in Jiaxing, to the south of Shanghai. The companies will focus primarily on the production of automated transmissions for heavy and light commercial vehicles.

Impacts of the adoption of the IFRS 16 standard at YIT and change in reporting practices

YIT Corporation Stock exchange release April, 18 2019 at 3:00 p.m.Impacts of the adoption of the IFRS 16 standard at YIT and change in reporting practice  YIT will change its reporting practices from 2019. This release describes the impacts of the adoption of the IFRS 16 “Leases” standard that entered into force on January 1, 2019. In addition, going forward, the company will not report figures under the percentage of completion (POC) principle. Impacts of the adoption of the IFRS 16 standard The new IFRS 16 “Leases” standard entered into force on January 1, 2019. The adoption of

STRAX:  ANNUAL REPORT 2018

STRAX has published the Annual Report for 2018 today. The Annual Report is available on the company’s homepage, www.strax.com For further information please contact Gudmundur Palmason, CEO, STRAX AB,+46 8 545 017 50. About STRAX STRAX is a market-leading global company specializing in mobile accessories. STRAX has built a House of Brands to complement its value-added customer specific solutions and services. STRAX House of Brands includes proprietary brands: XQISIT, Urbanista, THOR, CLCKR and licensed brands: adidas and bugatti. In addition, STRAX represents over 40 major

Invitation to Eltel’s first quarter 2019 interim report presentation

Eltel will publish its interim report for the first quarter 2019 on Friday 26 April 2019 at approximately 08.00 am CET. Eltel’s CEO Casimir Lindholm and CFO Petter Traaholt will host a presentation via audiocast in English starting at 10.00 am CET.The presentation will be audiocasted live on www.eltelgroup.com. For those who would like to participate in the telephone conference in connection with the presentation, the telephone numbers are: · SE: +46 8 505 583 58 · FI: +358 9 817 105 21 · UK: +44 33 330 092 65 Please, call well in advance to register. After the presentation,

Acando applies for delisting, appoints new CEO and CFO and sets new date for annual general meeting

CGI Inc. (“CGI”), through its indirect wholly-owned subsidiary CGI Nordic Holdings Limited, declared the public offer for Acando AB (publ) (“Acando”) unconditional on 16 April 2019. CGI holds more than 90 per cent of the shares in Acando and intends to request compulsory redemption regarding the remaining shares in the Acando. The board of directors of Acando has, at the request of CGI, today resolved to apply for delisting of Acando’s class B shares from Nasdaq Stockholm. The last day of trading in Acando’s shares on Nasdaq Stockholm will be announced as soon as Acando has received

SDLP - Seadrill Partners LLC receives early termination notice for the West Capricorn contract

London, United Kingdom, April 18, 2019 - Seadrill Partners LLC ("SDLP" or the "Company") has received early termination notice for the West Capricorn contract approximately three months ahead of schedule.  The contract was originally expected to run through late July 2019 and we now expect it to conclude in late April 2019 after the current well is completed and the unit is demobilized. Seadrill Partners will receive early termination payments over the original contract term and backlog is expected to decrease by $18 million. We continue to actively market the rig for deepwater and mid-

There are no items matching the current filter
There are no more items matching the current filter
Back to top